Lopinavir-Ritonavir

CHEBI:CHEBI_755236

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
311369
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
listing_expiration_date
20241231
pharm_class_moa
UDP Glucuronosyltransferases Inducers [MoA]
pharm_class
UDP Glucuronosyltransferases Inducers [MoA]
nui
N0000190117
dosage_form
SOLUTION
labeler_name
Lannett Company, Inc.
manufacturer_name
Lannett Company, Inc.
active_ingredient_strength
80 mg/mL
marketing_start_date
20161227
package_marketing_start_date
20161227
active_ingredient_name
LOPINAVIR
pharm_class_epc
Protease Inhibitor [EPC]
unii
O3J8G9O825
generic_name
Lopinavir-Ritonavir
brand_name
Lopinavir-Ritonavir
brand_name_base
Lopinavir-Ritonavir
product_ndc
0527-1947
application_number
ANDA207407
spl_id
751545a0-3b8c-4486-821d-94eb6383dc52
package_ndc
0527-1947-48
package_description
1 BOTTLE, PLASTIC in 1 CARTON (0527-1947-48) / 160 mL in 1 BOTTLE, PLASTIC
spl_set_id
4b1caefa-e6a2-42f3-9194-6dc1dd9e6d85
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class